放射性显影胶化乙醇治疗腰椎间盘突出症的长期临床疗效:一项多中心研究
这项双中心观察性研究评估了52例腰椎间盘突出症患者接受放射性显影胶化乙醇(DiscoGel®)治疗后的10年随访结果。治疗后10年,VAS疼痛评分和ODI功能评分均较术前有统计学显著改善(p < 0.01),且椎间盘前、中、后径线发生显著变化,其中前径与术前相比差异有统计学意义(p = 0.0011)。作者认为该疗法对保守治疗无效的症状性腰椎间盘突出症有前景,但需随机对照试验进一步验证。
要点
- 放射性显影胶化乙醇治疗腰椎间盘突出症后10年,VAS疼痛评分和ODI功能评分均较术前显著改善(p < 0.01)。
- 治疗后10年椎间盘前径较术前显著改变(p = 0.0011),提示RGE治疗后的结构适应。
- 作者认为该疗法对保守治疗无效的症状性腰椎间盘突出症有前景,但需随机对照试验与现有疗法比较。
核心结论
- RGE是保守治疗无效的症状性腰椎间盘突出症的一种有前景的治疗选择,可提供即时缓解和持久获益;但需进一步随机对照试验将DiscoGel®与既有治疗进行比较并证实其疗效。
研究设计与样本
- 双中心观察性研究,纳入2009年至2011年间接受腰椎RGE治疗且符合特定纳入和排除标准的患者52例(男26例、女26例,平均年龄51.7岁),收集术前影像、VAS疼痛评分和ODI功能评分并进行10年随访。
关键影像表现/征象
- 治疗后10年VAS疼痛评分和ODI百分比均较术前有统计学显著改善(p < 0.01)。
- 治疗后10年椎间盘前、中、后径线均观察到显著变化,提示RGE治疗后的结构适应。
- 治疗椎间盘前径在术后10年与术前测量值相比差异有统计学意义(p = 0.0011)。
临床应用与阅片要点
- 作者认为RGE是保守治疗无效的症状性腰椎间盘突出症的一种有前景的治疗选择,可提供即时缓解和持久获益。
- 作者指出需进一步随机对照试验将DiscoGel®与既有治疗进行比较并证实其疗效。
局限性
- 作者指出需进一步随机对照试验将DiscoGel®与既有治疗进行比较并证实其疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Degenerative and/or herniated discs are a global cause of chronic lower back and neck pain. While multiple treatments exist, the research for long-term effective interventions with minimal side effects continues. The radioplaque gelified ethanol (RGE) (DiscoGel®, Hérouville-Saint-Clair, France), is an addition to the armamentarium of potential treatments. This study aimed to evaluate the long-term efficacy of this device in treating lumbar disc herniation through a 10-year follow-up period.
METHODS: In this bi-centric observational study, patients treated with RGE in the lumbar spine between 2009 and 2011 were evaluated based on specific inclusion and exclusion criteria. Collected data encompassed preoperative imaging, VAS pain scores, ODI functional scores, were recorded through 10-year follow-up.
RESULTS: Fifty-two participants (26 males and 26 females) with an average age of 51.7 years were enrolled in the study. Ten years after treatment, there was a statistically significant improvement in VAS pain scores and ODI percentages (p < 0.01). Additionally, significant changes in anterior, medial, and posterior disc dimensions were observed, suggesting structural adaptations due to RGE treatment. A statistically significant difference in the anterior dimension of the treated disc was found 10 years postoperatively compared to preoperative measurements (p = 0.0011).
CONCLUSION: RGE is a promising therapeutic choice for lumbar symptomatic herniation resistant to conservative treatments, offering both immediate relief and enduring benefits. Although our findings are promising, additional randomized controlled trials are essential to compare DiscoGel® with established treatments and substantiate its efficacy.
引用
- Marcia S, Hirsch JA, Bellini M, et al. Long-term clinical efficacy of radioplaque gelified ethanol for lumbar disc herniation: a multicenter study. Neuroradiology. 2025. PMID: 40198365. doi:10.1007/s00234-025-03603-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。